Name: Ventyx Biosciences, Inc. (VTYX) Balance Sheet
Creator: FinSpry

Ventyx Biosciences Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Ventyx Biosciences, Inc. (VTYX) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	27.26	252.22	64.82	70.79	0.24
Short-Term Investments	190.06	200.64	253.12	187.79	0.00
Cash & Short-Term Investments	217.32	252.22	317.94	258.58	0.24
Accounts Receivable	1.00	0.80	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	12.30	1.87	12.75	4.44	0.00
Total Current Assets	229.63	264.35	330.69	263.02	0.25
Non-Current Assets
Property, Plant & Equipment (Net)	10.28	12.27	1.94	0.25	0.00
Long-Term Investments	35.62	0.00	38.67	28.15	0.00
Other Non-Current Assets	1.03	1.08	0.10	0.06	0.00
Total Non-Current Assets	46.94	13.35	40.71	28.46	0.00
Total Assets	276.56	277.69	371.40	291.48	0.25
Current Liabilities
Accounts Payable	3.13	21.26	6.43	4.66	1.10
Short-Term Debt	1.05	0.00	0.00	0.00	0.00
Accrued Liabilities	8.59	15.51	9.51	7.62	0.30
Other Current Liabilities	8.59	7.74	4.21	0.00	0.00
Total Current Liabilities	12.78	22.27	16.36	12.28	1.40
Non-Current Liabilities
Long-Term Debt	9.74	11.51	1.15	0.00	12.65
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	16.85
Total Non-Current Liabilities	9.74	11.51	1.15	0.00	0.00
Total Liabilities	22.52	33.77	17.51	12.28	30.90
Stockholders' Equity
Common Stock	0.01	0.01	0.01	0.01	0.00
Retained Earnings	-554.31	-419.24	-226.23	-117.80	-32.50
Accumulated Other Comprehensive Income	0.16	-0.05	-1.12	-0.06	0.00
Additional Paid-in Capital	808.19	663.15	581.24	397.05	0.00
Shares Outstanding	71.13	59.24	56.98	50.41	0.00
Total Stockholders' Equity	254.05	243.92	353.90	279.20	-30.65
Total Liabilities & Equity	276.56	277.69	371.40	291.48	0.00